The study found that after four years, patients using GLP-1 receptor agonists showed a 7 percent lower risk of developing any of 14 obesity-related cancers.
by is licensed under
Follow us
Read our latest news on any of these social networks!
Get latest news delivered daily!
We will send you breaking news right to your inbox